Cargando…
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study
OBJECTIVE: We aimed to determine the prevalence and risk factors for osteonecrosis of the femoral head (ONFH) in a multicentre cohort of patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV). METHODS: One hundred and eighty-six AAV patients who underwent radiographs and MRI s...
Autores principales: | Mimura, Norihiro, Iwamoto, Taro, Furuta, Shunsuke, Ikeda, Kei, Kobayashi, Yoshihisa, Nakamura, Takayuki, Saku, Aiko, Kagami, Shin-Ichiro, Matsuki, Ayako, Takahashi, Kentaro, Umibe, Takeshi, Nakagomi, Daiki, Sanayama, Yoshie, Sugimoto, Toyohiko, Fukuta, Masashi, Hiraguri, Masaki, Kawashima, Hirotoshi, Hirose, Koichi, Takatori, Hiroaki, Suehiro, Kenichi, Takahashi, Shigekazu, Tamachi, Tomohiro, Kato, Manami, Takizawa, Fumiyoshi, Kawarai, Yuya, Hagiwara, Shigeo, Nakamura, Junichi, Ohtori, Seiji, Nakajima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972441/ https://www.ncbi.nlm.nih.gov/pubmed/36849207 http://dx.doi.org/10.1136/rmdopen-2022-002787 |
Ejemplares similares
-
Daratumumab for the treatment of refractory ANCA-associated vasculitis
por: Ostendorf, Lennard, et al.
Publicado: (2023) -
Immune checkpoint inhibitors as potential triggers for ANCA vasculitis
por: Aqeel, Faten, et al.
Publicado: (2022) -
Risk factors for serious infections in ANCA-associated vasculitis
por: Odler, Balazs, et al.
Publicado: (2023) -
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020) -
CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis
por: Rousselle, Anthony, et al.
Publicado: (2022)